<p>Bars represent the maximum severity per volunteers within 28 days after either 2 vaccinations in Group A (separately for ADVAX and TBC-M4) or 3 vaccinations in Group B. Relative frequency of adverse events is plotted on the Y axis and Groups A, B vaccine or placebo recipients are plotted on the X-axis.</p
<p>The Y-axis of <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0041936#pone-...
Vaccination has been one of the most successful public health interventions to date, and the U.S. FD...
<p>The x-axis shows the number of participants experiencing adverse events, with the highest severit...
Frequency of related solicited adverse events experienced at least once; recorded at peak severity g...
<p>Number and percentages of participants with solicited adverse events after any vaccination, and u...
(A) Frequency of possibly, probably and definitely related (“Related”) unsolicited adverse events fr...
<p>Data are reported as: Number of participants with a serious adverse event (% [95% confidence inte...
<p>Solicited reactogenicity was collected for 7 days after each vaccination for 21 days total after ...
Reported local (A) and systemic (B) adverse events after the first (in blue) and second (in orange) ...
<p>(A) Placebo, (B) M01ZH09, and (C) Ty21a vaccine recipient groups. Maximum severity score per part...
<p>Comparison of solicited adverse events following the first and second doses of vaccine (n = 44) a...
AE: Adverse Events; 1 AstraZeneca includes the vaccines ChAdOx1 nCoV-19 and BBV152; *AE reported as ...
<p>Average number of possibly and probably related (both solicited and unsolicited) AE per previousl...
<p>Data are number (%) of participants experiencing an event after any vaccination. Results for the ...
Abstract Background Vaccination has been one of the m...
<p>The Y-axis of <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0041936#pone-...
Vaccination has been one of the most successful public health interventions to date, and the U.S. FD...
<p>The x-axis shows the number of participants experiencing adverse events, with the highest severit...
Frequency of related solicited adverse events experienced at least once; recorded at peak severity g...
<p>Number and percentages of participants with solicited adverse events after any vaccination, and u...
(A) Frequency of possibly, probably and definitely related (“Related”) unsolicited adverse events fr...
<p>Data are reported as: Number of participants with a serious adverse event (% [95% confidence inte...
<p>Solicited reactogenicity was collected for 7 days after each vaccination for 21 days total after ...
Reported local (A) and systemic (B) adverse events after the first (in blue) and second (in orange) ...
<p>(A) Placebo, (B) M01ZH09, and (C) Ty21a vaccine recipient groups. Maximum severity score per part...
<p>Comparison of solicited adverse events following the first and second doses of vaccine (n = 44) a...
AE: Adverse Events; 1 AstraZeneca includes the vaccines ChAdOx1 nCoV-19 and BBV152; *AE reported as ...
<p>Average number of possibly and probably related (both solicited and unsolicited) AE per previousl...
<p>Data are number (%) of participants experiencing an event after any vaccination. Results for the ...
Abstract Background Vaccination has been one of the m...
<p>The Y-axis of <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0041936#pone-...
Vaccination has been one of the most successful public health interventions to date, and the U.S. FD...
<p>The x-axis shows the number of participants experiencing adverse events, with the highest severit...